News tagged with renal cell carcinoma

Related topics:

Promising results shown for kidney cancer drug

The drug pazopanib (Votrient) slowed the progression of advanced renal cell carcinoma (RCC), a form of kidney cancer, in patients by 54% percent, according to a new study published in the Journal of Clinical Oncology.

dateFeb 04, 2010 in Cancer
shares0 comments 0
  • 1 2